Overview: Bone-Specific Alkaline Phosphatase TestIntroduction: The Bone-Specific Alkaline Phosphatase Test measures a bone-specific enzyme to diagnose bone disorders like osteoporosis or Paget's disease, which can cause bone pain or fractures. Aligned with 2023 bone health guidelines, it uses spectrophotometry for high accuracy, aiding in assessing bone turnover. This test is critical for guiding antiresorptive therapies, preventing fractures, and improving outcomes in bone health.
Other Names: BSAP Test, Bone ALP Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Bone-specific ALP was identified in the 1980s. Spectrophotometry emerged in the 1990s, and by the 2010s, specific assays improved clinical utility.
Purpose: Diagnoses bone disorders, guides therapy, and monitors disease in patients with bone pain or fracture risk.
Test Parameters: 1. Bone-Specific Alkaline Phosphatase
Pretest Condition: Fasting for 10-12 hours is required. Collect serum at any time. Report bone pain, fractures, or medications (e.g., bisphosphonates).
Specimen: 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document bone pain, fractures, or family history of bone disorders. Include current medications or vitamin D status.
Consent: Written consent required, explaining the test's purpose, diagnostic implications, and potential therapy needs.
Procedural Considerations: Uses spectrophotometry to measure bone-specific ALP. Results take 3-5 days due to assay specificity.
Factors Affecting Result Accuracy: Liver disease or medications may affect results. Hemolysis or improper storage can degrade samples.
Clinical Significance: Elevated BSAP suggests high bone turnover, prompting therapy for osteoporosis or Paget's disease. Normal levels may require monitoring.
Specialist Consultation: Consult an endocrinologist or rheumatologist for result interpretation. Orthopedic referral is advised for fractures.
Additional Supporting Tests: Bone density scan, serum calcium, or vitamin D levels to assess bone health.
Test Limitations: Non-specific elevation requires clinical correlation. Early disease may not elevate BSAP significantly.
References: NOF Osteoporosis Guidelines, 2023; Eastell R, Journal of Bone and Mineral Research, 2022.
